Latest / Stock Movers / Closing Bell: Tesla Jumps on Robotaxi Rollout, Circle Rises, Hims & Hers Sinks
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:09Speaker 2: This is the closing bell on this stock mover's report.
- 0:13Speaker 2: The company's making moves at the close of US trading
- 0:16Speaker 2: with Carol Masser, Tim Stenebeck, Romain, Bostik, and Scarlett, Foo.
- 0:22Speaker 3: S and P five DRED three hundred and ninety nine
- 0:24Speaker 3: names gaining ground in today's session. A lot of the
- 0:27Speaker 3: uptick towards the last ten to fifteen minutes of trading
- 0:30Speaker 3: one hundred and two Scarlet to the downside two unchanged.
- 0:33Speaker 4: Yeah, pretty lopsided advanced decline line. And you see that
- 0:35Speaker 4: reflected in the IMAP as well. This is eleven sectors
- 0:38Speaker 4: in the S and P five hundred and only one
- 0:40Speaker 4: sector finishing in the red, one of the smaller sectors,
- 0:43Speaker 4: and that is energy. In fact, you have twenty two
- 0:46Speaker 4: out of the twenty three big cap energy names losing ground.
- 0:49Speaker 4: Kinder Morgan was the only one to buck the decline.
- 0:52Speaker 3: All right, fascinating a lot of green there. I'm Tesla
- 0:54Speaker 3: definitely an owperformer. Number one gainor folks in the S
- 0:57Speaker 3: and P five hundred and NASDAQ one hundred. That's stack
- 0:59Speaker 3: up about eight and a quarter percent in today's session.
- 1:02Speaker 3: Biggest intry day rise since late April, the company coming
- 1:05Speaker 3: out launching it's much anticipated in long promise, Long long
- 1:09Speaker 3: long promise driver less taxi service to some riders. On Sunday,
- 1:12Speaker 3: analysts highlighting the low key and limited nature of the
- 1:15Speaker 3: rollout of the service in Austin, Texas, the debut was
- 1:18Speaker 3: quote unquote largely uneventful, which is always good, free of
- 1:21Speaker 3: major missteps, with the start of revenue service making a
- 1:24Speaker 3: critical milestone stone excuse me for bulls in the stock,
- 1:27Speaker 3: and they definitely moved into it in a big way.
- 1:30Speaker 3: Northern Trust want to point out that one up about
- 1:33Speaker 3: eight percent in today's session, shares rallying initially after The
- 1:36Speaker 3: Wall Street Journal came out earlier today and reported that
- 1:39Speaker 3: Bank of New York Mellon had approached the company in
- 1:41Speaker 3: recent days on a possible merger. So, if indeed we
- 1:45Speaker 3: see some kind of tie up between these two, you're
- 1:47Speaker 3: talking about two of the largest custodians custodian banks in
- 1:51Speaker 3: the world with a combined entity scale that would help
- 1:54Speaker 3: it and beat with global asset managers like black Rock
- 1:57Speaker 3: and Vanguard. So we'll be keeping our eye on that one.
- 2:00Speaker 3: And then I had to throw in circle Internet. I mean,
- 2:01Speaker 3: why not up another nine point six percent at its
- 2:04Speaker 3: highs It had rallied twenty four percent today, gaining almost
- 2:08Speaker 3: ten percent in today's session. So we're talking about a
- 2:11Speaker 3: sixty four to sixty five billion dollar market cap company
- 2:14Speaker 3: up about ninety percent or so in the past three
- 2:16Speaker 3: trading days. And it's up with it eight hundred percent
- 2:18Speaker 3: since its IPO on June fifth. So yeah, there you go.
- 2:22Speaker 5: Circle.
- 2:23Speaker 1: Hey, by the way, we're gonna have the Circle co
- 2:24Speaker 1: founder Sean Nevill on the program night.
- 2:27Speaker 3: All right, good booking.
- 2:29Speaker 5: All right, let's talk about some of the decliners today.
- 2:31Speaker 5: YMS and hear Hers Health fell more than thirty four percent.
- 2:34Speaker 5: Today was the most intra day ever. This after Novo
- 2:37Speaker 5: Nordis scrapped its partnership with Hymns and Hers it has
- 2:41Speaker 5: been selling compounded obesity drugs. On marketing concerns. Novo Nordisks
- 2:46Speaker 5: said Hymns was quote using deceptive marketing to sell copycat
- 2:49Speaker 5: versions of its obesity blockbuster we GOVI him CEO Andrew
- 2:54Speaker 5: Dudham on X called novo executive comments quote misleading. He
- 2:58Speaker 5: said Novo had been pressure Hymns to steer patients to
- 3:01Speaker 5: a govy regardless of whether it was clinically best for patients.
- 3:05Speaker 5: He said, quote we refused to be strong armed, and
- 3:08Speaker 5: that Hymns will continue to offer a wide range of treatments.
- 3:10Speaker 5: Interestingly enough, we saw Novo down five and a half percent.
- 3:14Speaker 1: I'm abstually fascinated by this story because, I mean, it
- 3:16Speaker 1: does seemed like the perfect marriage, right, I mean, you
- 3:18Speaker 1: talk about this idea of people wanting better access to
- 3:21Speaker 1: the drugs they want, not necessarily having to go through
- 3:23Speaker 1: the traditional doctor process, and of course Novo and other
- 3:26Speaker 1: drug companies wanting a more of a direct line to
- 3:28Speaker 1: their consumers. The fact that I don't know, something went
- 3:30Speaker 1: on behind the scenes that either Novo wasn't happy with
- 3:33Speaker 1: or maybe it was Hyms and Hers wasn't happy with,
- 3:35Speaker 1: I think says a lot. And it makes you wonder
- 3:37Speaker 1: about what these partnerships might look like in the future.
- 3:40Speaker 5: Yeah. I think it also says a lot that the
- 3:41Speaker 5: fact that Novos ADRs fell, you know, more than five
- 3:44Speaker 5: percent as a result of this too. Obviously investors thought
- 3:47Speaker 5: it was good a good way for the company to
- 3:49Speaker 5: get this medication into more hands. So yeah, again, we'll
- 3:52Speaker 5: see what those partnerships do look like in the future.
- 3:54Speaker 5: Moving on to super microcomputer, shares fell nine point eight
- 3:58Speaker 5: percent this after the company said it plans to off
- 3:59Speaker 5: for two billion dollars in convertible senior notes due in
- 4:02Speaker 5: twenty thirty. The company plans to use the proceeds to
- 4:06Speaker 5: repurchase shares as well as fund growth and business expansion.
- 4:08Speaker 5: This according to an announcement earlier today. And finally, ADRs
- 4:12Speaker 5: of Compass Pathways, this is a psychedelic drug company, this
- 4:19Speaker 5: medication company, a pharmaceutical company. We should not It's based
- 4:22Speaker 5: in the UK. Psychedelic drugs, right, yeah, it sounds like
- 4:26Speaker 5: I am right down forty nine percent. It's supposed to
- 4:29Speaker 5: treat a form of depression, but the trial disappointed investors.
- 4:34Speaker 5: The company said it's psilocybin drug reduced depression symptoms by
- 4:37Speaker 5: three point six percent on a rating scale compared to
- 4:40Speaker 5: a placebo but Wall Street wanted to see better results.
- 4:43Speaker 5: The study saw two hundred data adults for a change
- 4:46Speaker 5: in their symptoms at six weeks. This, according to a
- 4:49Speaker 5: statement from Compass Today. Once again, shares down forty nine percent.
- 4:52Speaker 6: Eight rs biotech special Right there, All right, guys, let's
- 4:54Speaker 6: get to the bond market here. So really interesting action
- 4:56Speaker 6: buying across the curve, particularly in the front end. Healds
- 4:59Speaker 6: down six spaces points. But the journey was really interesting.
- 5:02Speaker 6: So off the bat you had Michelle Bowman of the
- 5:04Speaker 6: FED speaking around ten o'clock this morning. I'm talking about
- 5:07Speaker 6: if inflation kept coming down in July, cut could be
- 5:09Speaker 6: in the cards. She also talked about the supplemental leverage
- 5:12Speaker 6: ratio that maybe the Fed will be discussing that on Wednesday.
- 5:16Speaker 6: That would reduce potentially the amount of money that banks
- 5:19Speaker 6: need to hold to account for risk. Right now, that
- 5:22Speaker 6: risk involves treasuries, which as we know, should be a
- 5:24Speaker 6: risk free asset, and if they can make that the
- 5:27Speaker 6: case and not have to hold money against treasuries, then
- 5:30Speaker 6: maybe they can actually buy more and have more money
- 5:32Speaker 6: to free up loan. So that all kind of playing
- 5:34Speaker 6: out within the treasury market. Clearly we marked the bottom though,
- 5:37Speaker 6: as we started to get these headlines out of President
- 5:41Speaker 6: Trump about potentially moving towards peace.
- 5:45Speaker 2: This stock mover's report from Bloomberg Radio. Check back with
- 5:49Speaker 2: us throughout the day for the latest roundup of companies
- 5:51Speaker 2: making news on Wall Street and for the latest market
- 5:54Speaker 2: moving headlines. Listen to Bloomberg Radio Live catch US on YouTube,
- 5:59Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 6:03Speaker 2: the Bloomberg Business app.
- 6:08Speaker 5: Mm hmm